Antiviral Drugs: An Overview Prof. Sri Agus Sudjarwo.,Ph.D.

Slides:



Advertisements
Similar presentations
Antiviral agents Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Advertisements

Treatment of AIDS “Antiretroviral therapy & vaccines”
ANTI VIRAL Agents Kaukab Azim, MBBS, PhD Modified by: iSRAA.
1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.
Antivirals Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant. It has.
Genetic Mutations Recombinant DNA Viruses Chapter 22 Nucleic Acids and Protein Synthesis.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
Lecture 29: Viruses 0.5 m.
Anti-HIV Drugs Cathy Molina November 11, Some HIV Facts HIV – the Human Immunodeficiency Virus is the retrovirus that causes AIDS HIV belongs to.
Antiviral Agents, chapter 39 Different living organisms.
Antiviral Drugs: HIV treatment Zach Laucis April 17 th, 2007.
Combination Antiretroviral Therapy for HIV Infection by Ormrat Kampeerawipakorn.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 40 Antiviral Drugs.
Antivirals for HIV Yasir Waheed, PhD. Some HIV Facts HIV – the Human Immunodeficiency Virus is the retrovirus that causes AIDS HIV belongs to the retrovirus.
Antiviral Drugs.
Antiviral Agents.
HIV/ AIDS Answers to your questions. What is HIV HIV- Human Immunodeficiency Virus HIV- Human Immunodeficiency Virus The virus attacks the T-Cells in.
HIV and AIDS Global: 40M HIV positive 25M AIDS deaths from ‘80 (60% sub-Saharan Africa) 80+% male Canada:63K HIV positive 16K AIDS deaths since 1980 (83%
Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs.
Antiviral Agents Upton D. Allen. Outline of Presentation Herpes group agents Anti-influenza agents Anti-hepatitis agents Anti-RSV Immune response modifiers.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 93 Antiviral Agents II: Drugs for HIV Infection and Related.
Antiviral Agents Restricted spectrum
Anti-HIV Drugs Melissa Morgan Medicinal Chemistry November 23, 2004.
27 MAR 2007 Antiviral Drugs: An Overview Chris Brooks CHEM 5398 Medicinal Chemistry Prof. Buynak.
Plate 36 Retroviruses.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 2 Characteristics of Viruses 3 Types of Viruses.
Antiviral Drugs Prof. Alhaider, 1431 H Definition: Viral infections depend on the host cells. Therefore, antiviral drugs must block viral entry or exit.
Medicines and Drugs Anti-virals Julia Barnes Anna Cruickshank.
Learning Objectives: Nucleic Acid therapeutics ReadingChapter 4, p from Blackburn & Gait Know the general mechanisms of the anti-cancer drugs.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Ch. 10 Molecular Biology of the Gene –
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
Antiviral Drugs. Mechanism of Action Picornaviruses eg, polioviruses, cold viruses Block attachment molecule on host cell or pathogen Attachment antagonists.
Antiviral Agents, chapter 39 Different living organisms.
Anti-viral drugs By Dr.Mohamed Abd ALMoneim Attia.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 39 Antiviral Drugs.
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
 Recognition  Attachment  Penetration  Uncoating  Early protein synthesis  Nucleic acid synthesis  Late protein synthesis  Assembly  Release.
Antivirals Lect 7,8 Sadia Anjum. Targets for Anti-viral therapy 1. viral attachment to cell and fusion (fusion inhibitors) 2. protein translation in infected.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
ANTIVIRAL AGENTS.
Antiviral drugs.
Basics of Human Immunodeficiency Virus (HIV) Brian Rybarczyk, PhD University of North Carolina- Chapel Hill.
Acyclovir Lee, sang-hwi.
The HIV virus. Objectives At the end of this session the participants will be able to: 1. Understand basic HIV structure 2. Describe the significance.
ANTIVIRAL THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
Antiviral Therapy. Table for antiviral Drug:Viruses: Chemical Type: Target: Acyclovir, VidarabineHerpesviruses (HSV) Nucleoside analogues Virus polymerase.
Antiviral Agents Dr. Yunita Sari Pane, MS 06 August DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU.
General, Organic, and Biological Chemistry Copyright © 2010 Pearson Education, Inc Viruses Chapter 21 Nucleic Acids and Protein Synthesis.
Viro100: Virology 3 Credit hours NUST Centre of Virology & Immunology
Retrovirus HIV (humans) Animal viruses resulting in cancer / AIDS 15-39%
© IAS–USA Johnson VA et al. Top Antivir Med. 2013;21(1):4-12. Updates, user notes, and references available at Mutations in the Reverse.
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
Antiviral agents Hamzeh Elayan
Antiviral Drugs.
Med Chem Tutoring January 25
Antiviral chemotherapy
Antiviral Drugs.
Assist . Prof . Karima F. Ali Al-Mustansiriyah university
Antiviral Drugs Chapter 45.
Antiviral Agents.
Chapter 18. Viral Genetics
Antiviral Agents Mr. Sachin Shinde S. M. Joshi College Hadapsar, Pune
Antiviral chemotherapy
Presentation transcript:

Antiviral Drugs: An Overview Prof. Sri Agus Sudjarwo.,Ph.D

The Outline 1.Viruses, what are they, who are they? 2.Virus Classifications 3.The virus, its hidden personal life 4.Methods of Attack 5.Drug Development 6.Antiviral Drugs 7.Conclusions and Overview

Different living organisms

Many different shapes Stages of replication May attack: Animals Plants Bacteria (Phages)

The Virus’ Personal Life

Stages of replication - DNA virus Attachment, penetration, uncoating, transfer of DNA to cell nucleus Assembly Release: Budding thru membranes (knoppskyting) Lysis Oncogenic viruses

Stages of replication - RNA virus More difficult to treath RNA virus infect. More mutation - Less repair mech. than with DNA (+) stranded RNA = mRNA Alternative A: (-) RNA virus Alternative B: (+) RNA virus (≠Retrovirus)Alternative C: Retrovirus; (+) RNA virus

Antiviral Drugs Amantadine and analogs Neuraminidase Inhibitors Nucleoside analogs - Antimetabolites Other comp. that interfere with replication Comp. that interfere with translation (protein synth) Interferon / interferon inducers Specific retroviral drugs Reverse transcriptase inhibitors Nucleosides (NRTIs) Non-nucleosides (NNRTIs) Protease inhibitors Effect against influenza A viruses No longer in use N. Inhib. penetration of RNA virus Inhib. uncoting

Neuraminidase Inhibitors Effect on influenza virus A and B(?) Inhib. neuraminidase (enzyme that breaks bonds between HA* in newly HA in formed virus and host cell) Prevents release of virus HA: Hemaglutinin, (glycoprotein) important for bonding between influenza virus and host

≈ S N 1 ≈ TS ‡ Zanamivir Relenza® Oseltamivir Tamiflu® (“Take my flu”)

Binding of oseltamivir to NA Basic centre better binding than DANA Hydrophobic pocket

Nucleoside analogs - Antimetabolites (C.f. anticancer compounds) Aciclovir® Zovirax® Valtrex® Guanosine analog Activity: DNA Herpes viruses (ex. Herpes simplex, varicella, cytomegalo, epstein barr)

Normal DNA / RNA chain

Relatet Structures Cymevene® Valcyte® Converted to triphosphates Inhibitors of viral DNA polymerases Gancyclovir: Not dependent of viral thymine kinase (better effect CMV, EB)

Ribavirin Copegus® Rebetol® Guanosine analog Fosforylated to triphosphate in vivo Inhib. viral RNA polymerase, RNA / DNA synthesis Broad spectrum (RNA and DNA viruses, some effect on HIV) Used against Hepatitis in N., serious side effects Thymidine analogs R = I, X = OH R = I, X = NH 2 (less tox) R = Br, X = OH R = F, X = OH R = CF 3, X = OH Incorp. DNA - faulty viral proteins Cytosine analogs Cytarabine (ARA-C) Cytarabin®, Cytosar®, Only cancer ther in N.

Adenosine analogs Fludarabine Fludara® cancer ther. Isolated Streptomyces antibioticus First studied as anticancer drug Interfere with DNA synth Tox. Rapid metab. adenosine deaminase Other comp. that interfere with replication Foscarnet Foscavir® Not orally avail. No in vivo activation required Inhib. DNA polymerase Neurotox. Also active against HIV Comp. that interfere with translation (protein synth) One of the oldest antiviral comp. known Inhib protein synth Methisazone

Interferon / interferon inducers Interferon: Rel small glycoproteins formed in virus infected cells (leukocytes, fibroblasts) Binds to surphase of other cells Initiates events leading to inhib. of mRNA trascrib. and translation Host spesific (not virus spesific) Interferon Inducers Double stranded RNA Heparin Dextranes Other bioplolymers Tilorone Side effects

Retrovirus HIV (humans) Animal viruses resulting in cancer / AIDS 15-39%

Stages of replication - RNA virus Alternative C: Retrovirus; (+) RNA virus Specific retroviral drugs Reverse transcriptase inhibitors Nucleosides (NRTIs) Non-nucleosides (NNRTIs) Protease inhibitors

Nucleoside Reverse Transcriptase Inhibitors Nucleoside analogs without 3’ OH - DNA chain termination Pro-drugs - Phosphorylated by kinases in vivo Zidovudine (AZT) Retrovir® Trizivir® Kombi prep. Stavudine Zerit® Zalcitabine (ddC)Lamividine (3TC) Epivir® Trizivir® Compivir ® Kombi prep. Didanosine (ddI) Videx® Abacavir (ABC) Trizivir® Kombi prep.

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) Efavirenz / Sustiva Stocrin® Nevirapin Viramune® J Med Chem 2004, 5923 FDA 1998 Already resistance activity resist strains Wild type RT mutated Binds directly to TR

Protease Inhibitors Solomon “oppgitt emne” Dec. 10th The HIV-1 protease is an enzyme crucial for the maturation and assembly of infectious viral particles

Science 1990, 249, 527 The two subunits are rotated 180 from each other J. Med. Chem. 1990,33, 2687 Design of C2 sym. comp. as TS(Intermed) analog of Phe-Pro cleavage (Type 1 comp. did not lead to drugs) X-ray: HIV-1 protease - C2 symmetric homodimeric -Not C2-sym. in related human proteases!

Ritonavir Norvir® -Bad water sol. and oral bioavail. -X-ray indicate modification of Cbz allowed M w >500! -Somewhat lower Mw -Thiazol instead of pyridine -FDA March 1996, now many resistant strains -Ritonavir inhib. 3A4 isozyme of CypP450 Used in combi. with other protease inhib. to suppress their metab.

Saquinavir (green) bound to HIV-1 Protease Saquinavir Fortovase® Indinavir Crixivan® Nelfinavir Viracept® Amprenavir Agenerase® Lopinavir Kaletra®